Conduit Pharmaceuticals I...
(CDT)
undefined
undefined%
At close: undefined
0.07
-0.55%
Pre-market Jan 06, 2025, 07:01 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 |
| Net Income | -535.00K | -4.89M | -3.66M |
| Depreciation & Amortization | n/a | n/a | n/a |
| Stock-Based Compensation | 199.00K | n/a | n/a |
| Other Working Capital | -2.73M | 927.00K | 1.36M |
| Other Non-Cash Items | -4.87M | 1.69M | 149.00K |
| Deferred Income Tax | n/a | n/a | n/a |
| Change in Working Capital | -2.52M | 927.00K | 1.36M |
| Operating Cash Flow | -7.72M | -2.27M | -2.15M |
| Capital Expenditures | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a |
| Purchase of Investments | n/a | -134.90M | n/a |
| Sales Maturities Of Investments | 497.00K | 148.00K | n/a |
| Other Investing Acitivies | 228.00K | 134.56M | n/a |
| Investing Cash Flow | 725.00K | -183.00K | 48.55K |
| Debt Repayment | 2.29M | 1.11M | 688.00K |
| Common Stock Repurchased | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a |
| Other Financial Acitivies | 8.64M | n/a | n/a |
| Financial Cash Flow | 10.93M | 2.45M | 1.90M |
| Net Cash Flow | 4.23M | 297.22K | -203.44K |
| Free Cash Flow | -7.72M | -2.27M | -2.15M |